IntelGenx Technologies Corp. Stock OTC Bulletin Board
Equities
IGX
US45822R1014
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2022 | 950K 1.31M | Sales 2023 | 1.04M 1.43M | Capitalization | 24.12M 33.17M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.75M | Net income 2023 | -9M -12.38M | EV / Sales 2022 | 44.7 x |
Net Debt 2022 | 7.98M 10.98M | Net Debt 2023 | 13.22M 18.18M | EV / Sales 2023 | 35.9 x |
P/E ratio 2022 |
-2.82
x | P/E ratio 2023 |
-2.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
Latest transcript on IntelGenx Technologies Corp.
Managers | Title | Age | Since |
---|---|---|---|
Dwight Gorham
CEO | Chief Executive Officer | 66 | 23-04-12 |
André Godin
DFI | Director of Finance/CFO | 61 | 15-07-19 |
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Horst Zerbe
CHM | Chairman | 77 | 06-03-31 |
Mark Nawacki
BRD | Director/Board Member | 54 | 16-08-08 |
Bernd Melchers
BRD | Director/Board Member | 72 | 09-04-07 |
1st Jan change | Capi. | |
---|---|---|
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+9.05% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |
- Stock Market
- Equities
- IGXT Stock
- IGX Stock